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ABSTRACT
Peptidases, their substrates and inhibitors are of
great relevance to biology, medicine and biotech-
nology. The MEROPS database (http://merops
.sanger.ac.uk) aims to fulfil the need for an
integrated source of information about these.
The database has a hierarchical classification
in which homologous sets of peptidases and
protein inhibitors are grouped into protein species,
which are grouped into families, which are in turn
grouped into clans. The classification framework is
used for attaching information at each level.
An important focus of the database has become
distinguishing one peptidase from another through
identifying the specificity of the peptidase in terms
of where it will cleave substrates and with which
inhibitors it will interact. We have collected over
39000 known cleavage sites in proteins, peptides
and synthetic substrates. These allow us to display
peptidase specificity and alignments of protein
substrates to give an indication of how well a
cleavage site is conserved, and thus its probable
physiological relevance. While the number of new
peptidase families and clans has only grown
slowly the number of complete genomes has
greatly increased. This has allowed us to add
an analysis tool to the relevant species pages to
show significant gains and losses of peptidase
genes relative to related species.
INTRODUCTION
The MEROPS database is a manually curated informa-
tion resource for peptidases (also known as proteases,
proteinases or proteolytic enzymes), their inhibitors and
substrates. The database has been in existence since 1996
and can be found at http://merops.sanger.ac.uk.
The organizational principle of the database is a
hierarchical classiﬁcation in which homologous sets of
peptidases and protein inhibitors are grouped into
protein species, which are in turn grouped into families,
which are grouped into clans. A family contains proteins
that can be shown to be related by sequence comparison
alone, whereas a clan contains proteins where the
sequences are so distantly related that similarity can
only be seen by comparing structures. Sequence analysis
is restricted to that portion of the protein directly respon-
sible for peptidase or inhibitor activity which is termed the
‘peptidase unit’ or the ‘inhibitor unit’, respectively.
A peptidase or inhibitor unit will normally correspond
to a structural domain, and some proteins will contain
more than one peptidase or inhibitor domain. Examples
are potato virus Y polyprotein which contains three
peptidase units, each in a diﬀerent family, and turkey
ovomucoid, which contains three inhibitor units all in
the same family. At every level in the database a well-
characterized type example is chosen, to which all other
members of the family or clan must be shown to be
related in a statistically signiﬁcant manner. The type
example at the peptidase or inhibitor level is termed the
‘holotype’ (1,2).
The MEROPS database is released quarterly and users
can now keep up to date with the latest MEROPS infor-
mation by subscribing to the MEROPS database Blog at
http://meropsdb.wordpress.com. Statistics from release
8.5 (August 2009) of MEROPS are shown in Table 1
and compared with release 7.8 from April 2007. The
number of peptidase sequences has more than doubled,
whereas the numbers of protein species, families and
clans has increased only slightly. The number of inhibitor
sequences has tripled, with the majority of increases in
three families (I1, I4 and I63) due to large numbers of
homologues being present in some eukaryote genomes.
These increases reﬂect the considerable eﬀort being put
into sequencing new genomes. It also demonstrates the
power of the peptidase classiﬁcation to make sense of
the data deluge.
In 2007 we published criteria for distinguishing one
peptidase from another (3), and in the last two years
much of our eﬀort has been focussed on implementing
these criteria in the MEROPS database. We have applied
these criteria to hypothetical peptidase homologues
identiﬁed by analysing completely sequenced genomes
(4), allowing us to assign a MEROPS identiﬁer where
appropriate. Two of the important distinguishing criteria
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arrangement of all the domains within the proteins.
The new displays discussed below make use of these
criteria and enable us to identify novel peptidases.
GENOME ANALYSES
The number of completely sequenced genomes from
cellular organisms now exceeds 1300. Because the
genomes from several strains of the same organism have
been sequenced, this represents the genomes of 780 diﬀer-
ent species. We have recently introduced a feature in the
organism species pages of MEROPS for a summary
analysis of the peptidase homologues. We highlight
instances where the genome contains members of a
peptidase family not found in 90% or more of other
closely related species (an unexpected presence), or
where a peptidase family is missing but present in 90%
or more of other closely related species (an unexpected
absence), or when the organism in question contains
more or less members of a peptidase family than any
other closely related species. This page is a product of
a CGI program which progresses up the organism classi-
ﬁcation starting from the family level towards
superkingdom, one taxon at a time, collecting the
number of species with completely sequence genomes.
When that number exceeds ﬁve, then the analysis is
performed and the results are presented at the foot
of the species page. An example analysis is shown in
Figure 1.
DOMAIN ARCHITECTURES
The images showing domain architectures have been over-
hauled. Because only the peptidase and inhibitor units are
classiﬁed in the MEROPS database, it can be useful to
compare the architectures of diﬀerent proteins within
the same peptidase or inhibitor family. This can now be
done for all the holotypes from a family by clicking on the
‘architecture’ button on the family page. An example of a
family architecture is shown in Figure 2.
SUBSTRATES AND SPECIFICITY DISPLAYS
One of the most important distinguishing features of a
peptidase is its speciﬁcity: where it will cleave a substrate
protein or peptide. The MEROPS substrate cleavage
collection began in 1998 with the publication of the
CD version of the Handbook of Proteolytic Enzymes
(5) and has now grown from 1919 cleavages in release
7.8 (April 2007) to include over 34000 known cleavages
in proteins and peptides (physiological and non-
physiological) and over 2700 cleavages in synthetic
substrates. Protein and peptide substrates are mapped to
a UniProt identiﬁer where possible, and the P1 residue for
each cleavage [the residue on the amino side of the scissile
bond (6)] mapped to a residue number within the UniProt
database entry. The peptidase responsible for the cleavage
is mapped to the MEROPS identiﬁer. We have recently
added cleavages to this collection that result in removal
of targeting signals from proteins, including initiating
methionines from cytoplasmic proteins by methionyl
aminopeptidases, the signal peptides from proteins
that enter the secretory pathway by signal peptidases,
and removal of targeting peptides for proteins that
are imported into chloroplasts, mitochondria and
peroxisomes. Only those cleavages that have been experi-
mentally veriﬁed, usually by N-terminal sequencing of
the mature protein, have been included.
We have introduced ‘ﬂags’ on the substrate pages to
indicate the method used to identify the cleavage
position. The ﬂags are as follows: NT shows that the
cleavage position was determined by N-Terminal
sequencing, MS shows that the peptide composition was
determined by mass-spectroscopy (MS) and the cleavage
position computed, MU shows that the cleavage position
was determined by site-directed MUtagenesis, CS
indicates that the cleavage position was postulated from
a consensus motif (CS) within the protein sequence.
Because the substrates as used by researchers are usually
mature proteins and peptides, the substrates page also
includes an extra column in the table to show the
residue range of the protein or peptide used in each study.
A tool has been assembled to allow the dynamic align-
ment of substrate protein sequences. On the assumption
that a physiologically relevant cleavage will be conserved
in orthologous protein sequences from closely related
organisms, cleavage sites are highlighted in the alignment
to show conservation or lack of it. Cleavage sites with
little conservation are probably fortuitous and of no
physiological signiﬁcance (though in a minority of cases
they may be pathological). For each substrate where
cleavages are known, the corresponding UniRef50 entry
(7) is found and all the UniProt protein sequences
included within that entry are aligned with MUSCLE (8).
It is assumed that most cleavages in native proteins
occur within surface loops and interdomain linkers.
Where the tertiary structure has been solved, the second-
ary structural elements are indicated on the substrate
alignment. An example protein substrate alignment with
secondary structure indicated is shown in Figure 3.
The display showing cleavages in a selected protein
depends on the user choosing the correct species from
which the substrate was derived. If no cleavages are
known for the user-selected protein but are known for
the same protein from a diﬀerent species, then an option
is automatically presented to display the sequence align-
ment with those cleavages highlighted.
Table 1. Counts of identiﬁers, families and clans for peptidase and
protein inhibitor homologues in the MEROPS database
MEROPS 7.8 MEROPS 8.5
Peptidases Inhibitors Peptidases Inhibitors
Sequences 66524 4912 140313 16337
Protein species 2403 571 3215 678
Families 185 53 208 66
Clans 51 33 52 34
The numbers in the current release of MEROPS (release 8.5, August
2009) are compared with release 7.8 from April 2007.
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indicate the speciﬁcity of a peptidase. This is shown as a
WebLogo (9) and a frequency matrix for the residues
accepted in binding pockets P4 to P40, provided we
know of 10 or more substrates. There are over 300
peptidases for which 10 or more substrates are known.
These displays are shown on the relevant peptidase
summary page. However, this does not allow easy com-
parison of one peptidase with another. So in addition to
the displays on a peptidase summary, MEROPS now
Figure 1. A summary analysis for the peptidase homologues from the completely sequence genome of the archaean Cenarchium symbiosum.
The ﬁgure is taken from the species page in the MEROPS website. A list of peptidase homologues arranged alphabetically by MEROPS identiﬁer
is shown in the top panel and the genome analysis is shown at the bottom of the page. The peptidase portion of the proteome of C. symbiosum (12)
has been compared with those of 17 other species from the class Thermoprotei. There are unexpected absences of members of peptidase families C26,
C44, M38, M48, S9 and U62, and an unexpected presence of a homologue from peptidase family M3. Of the species compared, C. symbiosum had
the fewest number of peptidase family M20 homologues, but the most for peptidase family S8. The large number of absent peptidase families may
indicates that this endosymbiont genome is degenerate.
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pockets S4 to S40. These show preference in terms of all
amino acids, amino acid properties and individual amino
acids. The ﬁrst of these shows, for each peptidase, an
amino acid if it occurs in the same binding pocket in
40% or more of the substrates. So no more than two
amino acids are shown for any one binding pocket. The
amino acid is shown with a green background, and
brighter the green, the greater the percentage of substrates
with the amino acid in that binding pocket. The second
display is similar but instead of showing individual amino
acids, these are collected into ‘aliphatic’, ‘aromatic’,
‘acidic, ‘basic’ or ‘small’ groups. In the third option the
user is prompted to select an amino acid from a pull-down
menu and the display shows the percentage of substrates
with the selected amino acid in each binding pocket for
each peptidase. Where an amino acid has not been
observed in a binding pocket, this is highlighted in
black. In all three displays where no amino acid is
possible (for example P4, P3 and P2 for an
aminopeptidase, of P20,P 3 0 or P40 for a carboxypeptidase)
the binding pocket is highlighted in grey. Figure 4 shows a
portion of one of these new displays.
ALIGNMENTS AND TREES
We have been aware that as more data are collected some
of our alignments are becoming very large. Not only will
there be hundreds (even thousands) of sequences, but the
consequences of aligning so many diverse sequences
means that more gap characters are inserted and the
alignments become wider. These are diﬃcult to view on
a computer screen, and on scrolling the screen, the residue
numbers or sequence identiﬁers disappear oﬀ screen.
To help to alleviate these problems, we have made our
dendrograms more interactive. The nodes of the tree are
Figure 2. The domain architectures for holotypes in peptidase subfamily M12B. The ﬁgure is taken from the domain architecture page for peptidase
subfamily M12B (the adamalysins) from the MEROPS website. The arrangement of regions and domains are shown for a selection of holotype
proteins. The structures are arranged from the top of the page in order of MEROPS identiﬁer. The name of the peptidase is given on the left-hand
side. All the structures are drawn to the same scale. The sequence length is denoted by the pale blue line. Regions and domains as determined
by MEROPS, the Pfam database and Swiss-Prot entries in the UniProt database (7), are shown as coloured rectangles on this bar. The domains
that are classiﬁed within the MEROPS database are shown as slightly larger boxes, in green for a peptidase unit and grey for an inhibitor unit
(not shown). The MEROPS identiﬁer is displayed in the centre in black text. Domains derived from the Pfam database (13) are shown as smaller
rectangles in crimson, with the domain name in white text. On clicking on the box, the user will be taken to the relevant Pfam entry. Regions from
Swiss-Prot include signal peptides and transmembrane regions (shown as even smaller boxes in black) and propeptides (in dark grey). Active site
residues (red ‘lollipops’) and metal ligands (blue ‘lollipops’) are shown along the bottom edge. Carbohydrate-binding residues (orange ‘lollipops’) and
disulphide bridges (black lines connecting the cysteines) are shown along the top edge. Mouse-over text gives details of the feature displayed in
all cases.
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of all the sequences derived from that node will be dis-
played. This alignment also includes the family type
example and the sequence numbering derived from the
type example sequence. The alignment displayed is not
dynamic, but is derived from the full alignment by
removing any insert characters common to all the
sequences. In order to make this happen, we are now
including the aligned peptidase or inhibitor unit sequences
and the dendrograms (in New Hampshire format) in the
MySQL database.
The sequence page of the peptidase (or inhibitor)
summary now includes an ALIGN VARIANTS button.
Many peptidases and inhibitors are sequenced many times
and variants exist, either strain-speciﬁc or the result of
alternative initiation, alternative splicing of exons, allelic
variation or single nucleotide polymorphisms (SNPs).
Clicking on the ALIGN VARIANTS button will
generate a dynamic alignment of all the variants we have
collected from the primary sequence databases. Residues
that diﬀer from the sequence we have selected for inclu-
sion in our protein sequence collection are highlighted as
white text on a black background.
NEW INDEXES
Indexes are important tools to allow users to ﬁnd the data
they want. We have added a number of new indexes to
MEROPS.
A new index of gene names has been added to the main
index page (the left-hand menu). You can now search for
any peptidase or protein inhibitor homologue knowing the
name of its gene or its gene locus.
A new substrate menu has been added, which includes
an index of substrate names to make it easier for the
user to ﬁnd a substrate for which we have cleavages
in our collection. Substrates are arranged alphabetically
by name. Names are usually taken from the UniProt
description, but where the substrate is a fragment of
a larger protein, the common name of the peptide is
favoured over the protein name. For example, a user
will ﬁnd ‘substance P’ in the index as well as the source
protein, ‘protachykinin-1’. The index also includes the
names of synthetic substrates. The substrate menu also
provides access to the pages that compare peptidase
speciﬁcity.
LITERATURE
The MEROPS database includes an extensive collection
of bibliographic references (over 37000). Each of these
references is tagged with the MEROPS identiﬁer for the
relevant peptidase, inhibitor, family or clan, and a list of
references is given for each peptidase, inhibitor, family or
clan. We have marked some of the publications that are
relevant to particularly important topics by use of
coloured ‘ﬂags’. The full list of ﬂags is shown in Table 2.
Figure 3. An example of a substrate protein sequence alignment. The ﬁgure is taken from the MEROPS website and shows a protein sequence
alignment of human C–X–C motif chemokine 11 and its close homologues, showing conservation around the matrix metallopeptidase 8 (MMP8,
M10.002) cleavage site at residue 84 (14). The sequence of the protein in which the cleavage was discovered is highlighted in green. Residues are
numbered according to this sequence. The MEROPS identiﬁers of the peptidases known to cleave this substrate are shown below the residue
numbers on the left. The arrows next to each MEROPS identiﬁer show the residue range of the peptide fragment used in the experiment, which in
most cases is the mature protein without the signal peptide (the signal peptidase cleavage at residue 22 is shown). A question mark instead of an
angled bracket would indicate that the terminus has not been determined. The scissile bond symbol (‘ ’) shows where cleavage occurs. Each symbol
can be clicked, and the alignment will be highlighted to show conservation around that cleavage site. Four residues either side of each cleavage site
(P4–P40) (6) are highlighted. Completely conserved residues are highlighted in orange. Although not shown in this example, a residue highlighted in
pink would not be conserved, but the amino acid would have been observed in the same position in another MMP8 substrate. Ile84 in the sequence
from the European ferret (Mustela putorius fero), labelled UniProt A8DBL7, is shown with a black background because isoleucine is unknown in this
position for any MMP8 substrate. The last line shows the secondary structure: an alpha helix is shown as a series of ‘a’s highlighted in red, and a
strand as a series of ‘b’s highlighted in green. This example shows that MMP8 is capable of cleaving this protein substrate within an alpha helix.
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A new item has been added to the Searches menu. The
MEROPS database includes many cross-references to
other databases and bioinformatics resources. To make
it easier for others to map their database entries
to MEROPS there is a new CGI that presents the
cross-references between MEROPS and any database
selected from a pull-down menu. There are a considerable
number of cross-references between MEROPS and
primary sequence databases, so these are returned in
batches of 50000.
A distributed annotation system (DAS) server (10) has
been set-up for MEROPS. This allows others to extract
data directly from the MEROPS MySQL database
for inclusion in their own Internet service. The user
enters an accession as a parameter in the URL (usually
this will be a UniProt accession, but an EMBL/GenBank
ProtID will work for MEROPS) and data relating
to the sequence stored in our collection will be returned.
For a peptidase or protein inhibitor, this will include
the MEROPS identiﬁer, family and clan, the extent
of the peptidase or inhibitor unit, active site residues
(and metal ligands for metallopeptidases), the amino
acid sequence and a link to a page in MEROPS for each
feature. For a protein substrate, positions of known
Figure 4. Comparison of peptidase speciﬁcity. The ﬁgure shows a portion of a page from the MEROPS website. Peptidase preference for the amino
acid proline is shown. The MEROPS identiﬁers and names of the peptidases are shown on the left, along with the number of substrate cleavages in
the MEROPS collection. Where proline occurs in the same position in 40% or more of substrates, the cell is highlighted in green and the percentage
of substrates with proline in this position is shown. Cells are only highlighted if 10 or more substrates are known for the peptidase. Where there can
be no binding pocket to accommodate a substrate residue, for example in position P4, P3 and P2 for an aminopeptidase or P20,P 3 0 and P40 for a
carboxypeptidase, these cells are highlighted in grey.
Table 2. Flags used to mark publications that are relevant to particu-
larly important topics and their explanation
Explanation
A Assay method,
E recombinant Expression,
I design of small-molecule Inhibitors,
K gene Knockout or other artiﬁcial genetic manipulation,
M natural Mutation, allelic variant or polymorphism,
P Substrate speciﬁcity,
R RNA splice variation,
S three-dimensional Structure,
T proposed as a therapeutic Target,
U suggested to have therapeutic potential itself,
V Review
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responsible are returned. Example URL’s are:
http://das.sanger.ac.uk/das/merops/features?segment=
P07858 (features for human cathepsin B)
http://das.sanger.ac.uk/das/merops/sequence?segment
=P07858 (sequence for human cathepsin B)
http://das.sanger.ac.uk/das/merops/features?segment=
P05067 (known cleavages for human amyloid beta A4
protein precursor)
ENHANCEMENTS TO EXISTING FEATURES
For eukaryotes with completely sequenced genomes, the
chromosomal location (in megabases) of the peptidase
or protein inhibitor homologue gene is now shown on
the organism page. These locations are derived from the
EnSEMBL database (11) by searching for entries with a
cross-reference to the UniProt protein sequence database,
therefore a location will not be shown for a gene from any
genome where the copy number is low. However, the
locations for all homologues from human and mouse are
shown. For human and mouse these locations are also
shown in the Genetics table of the peptidase or protein
inhibitor summary. Here the locations are linked to the
contig view in EnSEMBL, which shows the exon and
intron structure of the gene. The name of the chromosome
(or genomic scaﬀold) precedes the location and the strand
is indicated by a plus or minus sign in parentheses after the
location.
The displays of peptidase or inhibitor distribution
among organisms have been enhanced. There is now
mouse-over text at every node which gives the name of
the taxon.
MEROPS identiﬁers have been added to the tables of
peptidase-inhibitor interactions, and it is now possible to
order the tables according to the identiﬁer or the protein
name.
COMMUNITY ANNOTATION
Facilities have been set-up for our users to contribute
to annotation in MEROPS via a ‘Submissions’ button.
At present there are only two submission items, both
for advising us of any known protein cleavage sites that
we are unaware of. The ﬁrst of these is a form for the
submission of a single cleavage, and the second allows
the user to upload a ﬁle of known cleavage sites. The
latter has been designed with proteomics experiments in
mind. The information provided will allow us to map the
cleavage to an entry in the UniProt database. Users are
also welcome to send comments on any aspect of the
MEROPS website to the following E-mail address:
merops@sanger.ac.uk.
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